Targeted News Service
Targeted News Service provides Washington Bureau coverage, federal contract and contracting information for awards and for subcontracting opportunities, a congressional vote chart, federal and congressional press releases.
Stay updated with breaking news from Real World Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Targeted News Service provides Washington Bureau coverage, federal contract and contracting information for awards and for subcontracting opportunities, a congressional vote chart, federal and congressional press releases.
2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology...
The headlines — nearly 100 members of britain's governing conservative party have voted against new coronavirus restrictions in defiance of the prime minister, borisjohnson. however, the new restrictions were passed with the support of the opposition labour party. the world health organization has warned that the new omicron coronavirus variant is spreading at an unprecedented rate. the who director—general says it's likely that omicron is already present in most countries around the world. the first major real—world study since the omicron outbreak suggests that two doses of the pfizerj...
Nearly 100 members of britain's governing conservative party have voted against new coronavirus restrictions in defiance of the prime minister, borisjohnson. however, the new restrictions were passed with the support of the opposition labour party. the world health organization has warned that the new omicron coronavirus variant is spreading at an unprecedented rate. the who director general says it's likely that omicron is already present in most countries around the world. the first major real—world study since the omicron outbreak suggests that two doses of the pfizerjab appear to provide...
Two doses of Covaxin are 50 per cent effective against symptomatic Covid-19, according to the first real-world assessment of India's indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.